These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 31761617)

  • 21. Rich1 negatively regulates the epithelial cell cycle, proliferation and adhesion by CDC42/RAC1-PAK1-Erk1/2 pathway.
    Zhang J; Wang J; Zhou YF; Ren XY; Lin MM; Zhang QQ; Wang YH; Li X
    Cell Signal; 2015 Sep; 27(9):1703-12. PubMed ID: 26004135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NKCC1 promotes EMT-like process in GBM via RhoA and Rac1 signaling pathways.
    Ma H; Li T; Tao Z; Hai L; Tong L; Yi L; Abeysekera IR; Liu P; Xie Y; Li J; Yuan F; Zhang C; Yang Y; Ming H; Yu S; Yang X
    J Cell Physiol; 2019 Feb; 234(2):1630-1642. PubMed ID: 30159893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The novel GINS4 axis promotes gastric cancer growth and progression by activating Rac1 and CDC42.
    Zhu Z; Yu Z; Rong Z; Luo Z; Zhang J; Qiu Z; Huang C
    Theranostics; 2019; 9(26):8294-8311. PubMed ID: 31754397
    [No Abstract]   [Full Text] [Related]  

  • 24. RIT1 controls actin dynamics via complex formation with RAC1/CDC42 and PAK1.
    Meyer Zum Büschenfelde U; Brandenstein LI; von Elsner L; Flato K; Holling T; Zenker M; Rosenberger G; Kutsche K
    PLoS Genet; 2018 May; 14(5):e1007370. PubMed ID: 29734338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ARHGEF10L contributes to liver tumorigenesis through RhoA-ROCK1 signaling and the epithelial-mesenchymal transition.
    Tang J; Liu C; Xu B; Wang D; Ma Z; Chang X
    Exp Cell Res; 2019 Jan; 374(1):46-68. PubMed ID: 30444969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. R-Ketorolac Targets Cdc42 and Rac1 and Alters Ovarian Cancer Cell Behaviors Critical for Invasion and Metastasis.
    Guo Y; Kenney SR; Muller CY; Adams S; Rutledge T; Romero E; Murray-Krezan C; Prekeris R; Sklar LA; Hudson LG; Wandinger-Ness A
    Mol Cancer Ther; 2015 Oct; 14(10):2215-27. PubMed ID: 26206334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rac1/PAK1 signaling promotes epithelial-mesenchymal transition of podocytes in vitro via triggering β-catenin transcriptional activity under high glucose conditions.
    Lv Z; Hu M; Zhen J; Lin J; Wang Q; Wang R
    Int J Biochem Cell Biol; 2013 Feb; 45(2):255-64. PubMed ID: 23153508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. POTEE promotes colorectal carcinoma progression via activating the Rac1/Cdc42 pathway.
    Xu Q; Chen J; Peng M; Duan S; Hu Y; Guo D; Geng J; Zhou J
    Exp Cell Res; 2020 May; 390(1):111933. PubMed ID: 32142855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Shank family of postsynaptic density proteins interacts with and promotes synaptic accumulation of the beta PIX guanine nucleotide exchange factor for Rac1 and Cdc42.
    Park E; Na M; Choi J; Kim S; Lee JR; Yoon J; Park D; Sheng M; Kim E
    J Biol Chem; 2003 May; 278(21):19220-9. PubMed ID: 12626503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting PAK4 Inhibits Ras-Mediated Signaling and Multiple Oncogenic Pathways in High-Risk Rhabdomyosarcoma.
    Dasgupta A; Sierra L; Tsang SV; Kurenbekova L; Patel T; Rajapakse K; Shuck RL; Rainusso N; Landesman Y; Unger T; Coarfa C; Yustein JT
    Cancer Res; 2021 Jan; 81(1):199-212. PubMed ID: 33168646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pak1 kinase homodimers are autoinhibited in trans and dissociated upon activation by Cdc42 and Rac1.
    Parrini MC; Lei M; Harrison SC; Mayer BJ
    Mol Cell; 2002 Jan; 9(1):73-83. PubMed ID: 11804587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting Cdc42 with the small molecule drug AZA197 suppresses primary colon cancer growth and prolongs survival in a preclinical mouse xenograft model by downregulation of PAK1 activity.
    Zins K; Gunawardhana S; Lucas T; Abraham D; Aharinejad S
    J Transl Med; 2013 Nov; 11():295. PubMed ID: 24279335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-130b directly targets ARHGAP1 to drive activation of a metastatic CDC42-PAK1-AP1 positive feedback loop in Ewing sarcoma.
    Satterfield L; Shuck R; Kurenbekova L; Allen-Rhoades W; Edwards D; Huang S; Rajapakshe K; Coarfa C; Donehower LA; Yustein JT
    Int J Cancer; 2017 Nov; 141(10):2062-2075. PubMed ID: 28748534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The guanine nucleotide exchange factor Tiam1: a Janus-faced molecule in cellular signaling.
    Boissier P; Huynh-Do U
    Cell Signal; 2014 Mar; 26(3):483-91. PubMed ID: 24308970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rho GTPases RhoA and Rac1 mediate effects of dietary folate on metastatic potential of A549 cancer cells through the control of cofilin phosphorylation.
    Oleinik NV; Helke KL; Kistner-Griffin E; Krupenko NI; Krupenko SA
    J Biol Chem; 2014 Sep; 289(38):26383-26394. PubMed ID: 25086046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of small GTPase signaling pathways using p21-activated kinase mutants that selectively couple to Cdc42.
    Reeder MK; Serebriiskii IG; Golemis EA; Chernoff J
    J Biol Chem; 2001 Nov; 276(44):40606-13. PubMed ID: 11514549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GIT1 promotes lung cancer cell metastasis through modulating Rac1/Cdc42 activity and is associated with poor prognosis.
    Chang JS; Su CY; Yu WH; Lee WJ; Liu YP; Lai TC; Jan YH; Yang YF; Shen CN; Shew JY; Lu J; Yang CJ; Huang MS; Lu PJ; Lin YF; Kuo ML; Hua KT; Hsiao M
    Oncotarget; 2015 Nov; 6(34):36278-91. PubMed ID: 26462147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GRHL2 inhibits colorectal cancer progression and metastasis via oppressing epithelial-mesenchymal transition.
    Yang Z; Wu D; Chen Y; Min Z; Quan Y
    Cancer Biol Ther; 2019; 20(9):1195-1205. PubMed ID: 31063022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cdc42 and Rac1 activity is reduced in human pheochromocytoma and correlates with FARP1 and ARHGEF1 expression.
    Croisé P; Houy S; Gand M; Lanoix J; Calco V; Tóth P; Brunaud L; Lomazzi S; Paramithiotis E; Chelsky D; Ory S; Gasman S
    Endocr Relat Cancer; 2016 Apr; 23(4):281-93. PubMed ID: 26911374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-874 functions as a tumor suppressor in rhabdomyosarcoma by directly targeting GEFT.
    Shang H; Liu Y; Li Z; Liu Q; Cui W; Zhang L; Pang Y; Liu C; Li F
    Am J Cancer Res; 2019; 9(4):668-681. PubMed ID: 31105995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.